Datasets:
timotheeplanes
/
doping

Dataset card Data Studio Files
xet
 Community
1
text
stringlengths
1
17.8k
7.1 Responsibility for Conducting Results Management 7.1.1 For Results Management relating to a Sample collected by the ITA on behalf of the IOC in accordance with Article 5 of these Rules or an anti -doping rule violation occurring during the Olympic Games Paris 2024 , the IOC shall assume Results Management responsibility to determine whether an anti -doping rul e violation was committed and, if so, all Consequences flowing from the anti -doping rule violation(s), including the applicable Disqualifications and other Consequences under Articles 9 , 10.1, 10.2 and 11 of these Rules , the forfeiture of any medals, diplomas, points and prizes from the Olympic Games Paris 2024 , and any recovery of costs appli cable to the anti -doping rule violation.
However , as part of its delegated responsibilities , the ITA shall be responsible to represent the IOC and act on its behalf and name in the conduct of the Results Management process for anti -doping rule violations arising under these Rules .
Without limitation, the ITA shall notably conduct the reviews provided for in this Article 7.
7.1.2 Responsibility for the completion of R esults Management and the conduct of hearings for anti -doping rule violations arising under these Rules in relation to Consequences that extend beyond the Olympic Games Paris 2024 shall be referred to the Athlete or ot her Person ’s International Federation .
7.2 Review of Adverse Analytical Findings Results Management in respect of the results of tests initiated and conducted by the ITA pursuant to these Rules (including any tests performed by WADA in accordance with Article 5.2.
6 of these Rules ) shall proceed as follows: IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 19 / 49 7.2.1 The results from all analyses will be reported into ADAMS whether during or outside the Period of the Pre -Olympic Games Paris 2024 and the Period of the Olympic Games Paris 2024 .
All communications and reports must be provided in a manner preserving confidentiality and data privacy , in conformity with the International Standard for Laboratories , the International Standard for the Protection of Privacy and Personal Information, the applicable data protection and privacy laws and reported into ADAMS as applicable .
7.2.2 Initial Review 7.2.2.1 Upon receipt of an Adverse Analytical Finding , the I TA shall conduct a review to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions (as set out in Article 7.2.2.3 below) ; (b) there is any apparent departure from the International Standard for Testing and Investigations or International Standard for Laboratories that caused the Adverse Analytical Finding (as set out in Article 7.2.2.4 below) ; and/or (c) it is apparent that the Adverse An alytical Finding was caused by an ingestion of the relevant Prohibited Substance through a permitted route (as set out in Article 7.2.2.5 below) .
7.2.2.2 The ITA may, without limitation, request additional information, documents and explanations related to the re view of an Adverse Analytical Finding , including regarding the route of administration and posology , from the Athlete or any other Person .
The ITA may also liaise with third parties in order to assess the validity of the information, documents and/or explanations .
7.2.2.3 The ITA shall consult the Athlete ’s records in ADAMS and with other Anti-Doping Organisations that might have approved a TUE for the Athlete to determine whether a TUE exists .
If the initial review reveals that the Athlete has an applicable TUE, then the ITA shall conduct such follow up review as necessary to determine if the specific requirements of the TUE have been complied with.
7.2.2.4 The ITA must review the Adverse Analytical Finding to determine if there has been any departure from the International Standard for Testing and Investigations and/or the International Standard for Laboratories .
This may include a review of the Laboratory Documentation Package produced by the l aboratory to support the Adverse Analytical Finding (if available at the time of the review) and relevant Doping Control form(s) and Testing documents.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 20 / 49 7.2.2.5 If the Adverse Analytical Finding involves a Prohibited Substance permitted through (a) specific route(s) as per the Prohibited List, the ITA shall consult any relevant available documentation (e.g.
Doping Control form or records of the Olympic Village Polyclinic or other official medical stations ) to determine whether the Prohibited Substance appears to have been administered through a permitted route and, if so, shall consult an expert to determine whether the Adverse Analytical Finding is compatible with the apparent route of ingestion.
7.2.3 Notific ation 7.2.3.1 If the review of an Adverse Analytical Finding under Article 7.2.2 of these Rules does not reveal an applicable TUE or entitlement to a TUE as provided in the International Standard for Therapeutic Use Exemptions , an apparent departure from the International Standard for Testing and Investigations or the International Standard for Laboratories that caused the Adverse Analytical Finding or that it is apparent that the Adverse Analytical Finding was caused by an ingestion of the relevant Prohibited Substance through a permitted route , the ITA shall promptly notify: (a) the Athlete; (b) the Athlete’s NOC ; (c) the Athlete’s International Federation (who will be entitled to send a representative(s) to attend the hearing); (d) the relevant National Anti -Doping Organisation of the Athlete ; (e) the IOC; and (f) WADA (which will be entitled to send a representative to attend the hearing) and, during the Period of the Olympic Games Paris 2024 , a representative of the Independent Observer Program me of the existence of the Adverse Analytical Finding , and the essential details available concerning the case as further set out in Article 7.2.
3.2 below , and promptly report it into ADAMS .
7.2.3.2 The notifications specified above under Article 7.2.
3.1 (a) to (f ) shall be done in the manner set out in Article s 13.1 and 14 , and shall include : (a) the Adverse Analytical Finding ; (b) the fact that the Adverse Analytical Finding may result in an anti-doping rul e violation of the Article 2.1 and/or Article 2.2. of these Rules and the applicable Consequences ; (c) the Athlete 's right to request the analysis of the B Sample or, failing such request, that the B Sample analysis may be deemed irrevocably waived; (d) the scheduled date, time and place for the B Sample analysis if the Athlete or the ITA chooses to request an analysis of the B Sample .
It shall be indicated either in the notification described in this Article 7.2.3.2 or in a subsequent letter promptly after the Athlete or the ITA has requested the B Sample analysis ; IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 21 / 49 (e) the opportunity for the Athlete and/or the Athlete 's representative to attend the B Sample opening and analysis in accordance with the International Standard for Laboratories if such analysis is requested; (f) the Athlete 's right to request copies of the A and B Sample Laboratory Documentation Package which includes information as required by the International Standard for Laboratories ; (g) the opportunity for the Athlete to provide an explanation within a reasonable deadline taking into consideration the circumstances ; (h) the opportunity for the Athlete to provide Substantial Assistance as set out under Article 10.7.1 of the Code , to admit the anti-doping rule violation and potentially benefit from the regime set out in Articles 10.8.1 or to seek to enter into a case res olution agreement under Article of 10.8.2 of the Code (if applicable) which may be granted at the occasion of the completion o f Results Management proceedings conducted by the applicable International Federation in accordance with Article 7.1.2 of these Rules ; and (i) to the extent applicable, the fact that mandatory or optional Provisional Suspension is imposed or sought (including the possibility for the Athlete to accept a voluntary Provisional Suspension as per Article 7.7 of these Rules ) and that an opportunity for a Provisional Hearing or an expedited final hearing when a Provisional Suspension has been imposed or is sought either under Articles 7.6.1 or 7.6.2 .
7.2.3.3 In the event that th e Adverse Analytical Finding relates to Prohibited Substances described in the International Standard for Results Management (such as salbutamol, formoterol or other Prohibited Substance subject to specific Results Management requirements in a Technical Document or other document issued by WADA ), the ITA shall act in accordance with the requirements set forth in the International Standard for Results Management.
7.2.3.4 Where requested by the Athlete or the ITA, arrangements may be made to analyse the B Sample in accordance with the International Standard for Laboratories and the International Standard for Results Management.
The timing of the B Sample analysis may be strictly fixed in the short term with no postponement possible, when circumstances justify it in accordance with the International Standard for Laboratories.
An Athlete may accept the A Sample analytical results by waiving the requirement for B Sample analysis.
The ITA may nonetheless elect to proceed with the B Sample analysis.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 22 / 49 7.2.3.5 The Athlete and/or Athlete ’s representative shall be allowed to be present at the opening and analysis of the B Sample .
Also, a representative of the ITA shall be allowed to be present.
If the Athlete and the Athlete’s representative claim not to be available on the scheduled date, time and place, or on two alternative occasions (which during the Olympic Games Paris 2024 may be limited to two alternative times within the same date) , the ITA may instruct the laboratory to proceed regardless and appoint an Independent Witness to verify that the B Sample container shows no signs of Tampering and that the identifying numbers match that on the collection documentation.
An Independent Witness may be appointed even if the Athlete has indicated that the Athlete and/or the Athlete ’s representative be present.
7.2.3.6 If the results of the B Sample analysis confirms the results of the A Sample analysis, the results shall be promptly notified to the Athlete , the Athlete’s NOC, the Athlete's International Federation, the relevant National Anti -Doping Organisation of the Athlete , the IOC and to WADA , and a short deadline taking into consideration the circumstances shall be granted to the Athlete to provide or supplement the Athlete ’s explanations .
The Athlete shall be afforded the possibility to admit the anti-doping rule violation and potentially benefit from the regime set out in Articles 10.8.1 of the Code which may be granted at the occasion of the completion of Results Management proceedings conducted by the applicable International Federation in accordance with Article 7.1.2 of these Rules , if applicable, and/or voluntarily accept a Provisional Suspension as per Article 7.7 of these Rules .
7.2.3.7 The notification under Article 7.2.3.1 of these Rules to the Athlete shall constitute the commencement of the proceeding in respect of the anti-doping rule violation for the purposes of Article 1 7 of these Rules .
7.2.3.8 In parallel or upon conclusion of the notification process hereinabove , an application pursuant to Article 8.1.1 of these Rules shall be filed by the ITA with the CAS Anti -Doping Division, as per Article 8 of these Rules and the CAS Anti-Doping Division Arbitration Rules , where necessary .
7.3 Review of Atypical Findings 7.3.1 Upon receipt of an Atypical Finding , the ITA shall conduct a review to determine whether: (a) an applicable TUE has been granted or will be granted as provided in the International Standard for Therapeutic Use Exemptions (as set out in Article 7.2.2.3 above by analogy) ; (b) there is any apparent departure from the International Standard for Testing and Investigations or International Standard for Laboratories that caused the Atypical Finding (as set out in Article 7.2.2.4 above by analogy) ; and/or (c) it is apparent that the Atypical Finding was caused by an ingestion of the relevant Prohibited Substance through a permitted route (as set out in Article 7.2.2.
5 above by analogy ).
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 23 / 49 7.3.2 If the review set out in Article 7 .3.1 of these Rules does not reveal an applicable TUE, an apparent departure from the International Standard for Testing and Investigations or the International Standard for Laboratories that caused the Atypical Finding , or that it is apparent that the Atypical Finding was caused by an ingestion of the relevant Prohibited Substance through a permitted route, the ITA shall conduct the required investigation or cause it to be conducted.
7.3.3 The ITA will not provide noti fication of an Atypical Finding until it has completed its investigation and has decided that it will bring the Atypical Finding forward as an Adverse Analytical Finding unless one of the following circumstances exists: (a) if the ITA determines that the B Sample should be analysed prior to the conclusion of its investigation.
In this case , the ITA may conduct the B Sample analysis after notifying the Athlete , with such notification to include a description of the Atypical Finding and the information describ ed in Article 7.2.
3.2 (c) - (f); or (b) if the ITA receives a request, either from a Major Event Organi sation shortly before one of its International Events or from a sport organi sation responsible for meeting an imminent deadline for selecting team members for an International Event, to disclose whether any Athlete identified on a list provided by the Major Event Organi sation or sport organi sation has a pending Atypical Finding , the ITA shall identify any Athlete after first providing notice of the Atypical Finding to the Athlete ; or (c) if the Atypical Finding is, in the opinion of qualified medical or expert personnel, likely to be connected to a serious pathology that requires urgent medical attention; or (d) if further information from the Athlete is required to assess the Atypical Finding pursuant to WADA guidelines and Technical Documents , such as the WADA Stakeholder Notice regarding potential diuretic contamination cases and meat contamination.
7.3.4 If after the investigation is completed the ITA decides to pursue the Atypical Finding as an Adverse Analytical Finding , then the procedure shall follow the provisions of Article 7.2 of these Rules mutatis mutandis .
7.4 Matters not Involving an Adverse Analytical Finding or Atypical Finding 7.4.1 Specific cases The pre-adjudication phase of Results Management of a possible failure to comply , potential whereabouts failures and Adverse Passport Findings , shall take place as provided in and in accordance with the International Standard for Results Management .
For the sake of clarity, apparent whereabouts failures as per Article B.3.2.a) of the International Standard for Results Management, that is apparent whereabouts failures uncovered by an attempt to test, will be referred by the ITA for the Results Management by the competent Athlete ’s Results Management authority with which the respective Athlete files his/her whereabouts information .
Moreover, as the IOC is not a Passport Custodian (as defined in the International Standard for Results Management) , all Adverse Passport IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 24 / 49 Findings shall be reported to the competent Athlete ’s Results Management authority.
7.4.2 Notification for specific cases under Article 7.4.1 of these Rules and other Anti -Doping rules violations not involving an Adverse Analytical Finding or Atypical Finding 7.4.2.1 At such time as the ITA considers that the Athlete or other Person may have committed (an) anti-doping rule violation(s) for which the IOC is the Results Management authority pursuant to the Code, the International Standard for Results Management and these Rules , the ITA shall promptly notify : (a) the Athlete or other Person ; (b) the Athlete’s or other Person’s NOC; (c) the Athlete’s or other Person’s International Federation (who will be entitled to send a representative(s) to attend the hearing); (d) the relevant National Anti -Doping Organisation of the Athlete or oth er Person ; (e) the IOC; and (f) WADA (which will be entitled to send a representative to attend the hearing) and, during the Period of the Olympic Games Paris 2024 , a representative of the Independent Observer Programme of the alleged anti -doping rule violation(s) and the essential details available concerning the case as further set out in Article 7.4.
2.2 below , and promptly report it into ADAMS .
7.4.2.2 The notifications specified above under Article 7.4.2.1 (a) to (f) shall be done in the manner set out in Articles 13.1 and 14, and shall include : (a) the relevant anti-doping rule violation(s) and the applicable Consequences ; (b) the relevant factual circumstances upon which the allegations are based; (c) the relevant evidence in support of those facts that the ITA considers demonstrate that the Athlete or other Person may have committed (an) anti -doping rule violation(s); (d) the right for the Athlete or other Person to provide an explanation within a reasonable deadline taking into consideration the circumstances ; (e) the opportunity for the Athlete or other Person to provide Substantial Assistance as set out under Article 10.7.1 of the Code, to admit the anti-doping rule violation and potentially benefit from the regime set out in Articles 10.8.1 or to seek to enter into a case resolution agreement under Article of 10.8.2 of the Code (if applicable) which may be granted at the occasion of the completion of Results Management proceedings conducted by the applicable International Federation in accordance with Article 7.1.2 of these Rules ; and IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 25 / 49 (f) to the extent applicable, the fact that mandatory or optional Provisional Suspension is imposed or sought (including the possibility for the Athlete or other Person to accept a voluntary Provisional Suspension as per Article 7.7 of these Rules ) and that an opportunity for a Provisional Hearing or an expedited final hearing when a Provisional Suspension has bee n imposed or is sought either under Articles 7.6.1 or 7.6.2 .
7.4.2.3 The ITA may, without limitation, request additional information, documents and explanations related to the review of a potential anti-doping rule violation, from the Athlete or any other Person .
The ITA may also liaise with third parties in order to assess the validity of the information, documents and/or explanations.
7.4.2.4 The notification of the Athlete or other Person pursuant to Article 7.4.2.1 of these Rules shall constitute the commencement of the proceeding in respect of the anti-doping rule violation for the purposes of Article 1 7 of these Rules .
7.4.2.5 In parallel or upon conclusion of the notification process hereinabove , an application pursuant to Article 8.1.1 of the se Rules shall be filed by the ITA with the CAS Anti -Doping Division, in accordance with Article 8 of these Rules and the CAS Anti -Doping Division Arbitration Rules .
7.5 Decision Not to Move Forward If at any point during the Results Management up until the application to the CAS Anti -Doping Division pursuant to Article 8.1.1 of these Rules , the ITA decides not to move forward with a matter, the Athlete or other Person (provided that the Athlete or other Person had been already informed of the ongoing Results Management) , the Athlete’s or other Person’s NOC, the Athlete's or other Person’s International Federation, the relevant National Anti -Doping Organisation of the Athlete or other Person , the IOC and WADA shall be so notified.
7.6 Provisional Suspensions 7.6.1 Mandatory Provisional Suspension after an Adverse Analytical Finding or Adverse Passport Finding If analysis of an A Sample has resulted in an Adverse Analytical Finding or Adverse Passport Finding (upon completion of the Adverse Passport Finding review process) for a Prohibited Substance or a Prohibited Method , other than a Specified Substance or Specified Method , and a review in accordance with Article 7.2.2 of these Rules does not reveal an applicable TUE or an apparent departure from the International Standard for Testing and Investigations or the International Standard for Laboratories that caused the Adverse Analytical Finding or that it is apparent that the Adverse Analytical Finding was caused by an ingestion of the relevant Prohibited Substance through a permitted route , a Provisional Suspension shall be imposed by the ITA and/or CAS Anti-Doping Division promptly upon or after the review and notification described in Article 7.2.
3 of these Rules , provided that the Athlete or other Person is given the opportunity to be heard as specified in Article 7.6.3 .
In accordance with Article 7.1.2 of these Rules , the scope of the Provisional Suspension shall be limited to the Olympic Games Paris 2024 .
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 26 / 49 7.6.2 Optional Provisional Suspension Based on an Adverse Analytical Finding for Specified Substances , Specified Methods , Contaminated Products or Other Anti -Doping Rule Violations In case of any other anti-doping rule violations not covered by Article 7.6.1, a Provisional Suspension on the Athlete or other Person against whom the a nti-doping rule violation is asserted may be imposed by the ITA and/or CAS Anti -Doping Division upon or promptly after the notification described in Article 7.2.
3 or Article 7.
4.2 and the Athlete or other Person being given the opportunity to be heard as specified in Article 7.6.3.
In accordance with Article 7.1.2, the scope of the Provisional Suspension shall be limited to the Olympic Games Paris 2024 .
7.6.3 Opportunity for Hearing or Appeal The Athlete or other Person against whom a Provisional Suspension has been imposed or is sought either under Articles 7.6.1 or 7.6.2 shall be given an opportunity for a Provisional Hearing or an expedited final hearing before the CAS Anti -Doping Division on a timely basis , which may be he ld by tele -conference , video -conference or written submissions , before or after the imposition (in that case to reconsider a decision issued without a hearing) of the Provisional Suspension.
The Athlete or other Person may expressly or impliedly (e.g.
by failing to respond withi n the set deadline) waive the right to ask for a Provisional Hearing or expedited final hearing before the CAS Anti -Doping Division.
The imposition of a Provisional Suspension , or the decision not to impose a Provisional Suspension, may also be appealed in an expedite d procedure in accordance with Article 12 of these Rules .
7.6.4 The mandatory Provisional Suspension may be lifted if the Athlete demonstrates to the CAS Anti -Doping Division that the anti-doping rule violation is likely to have involved a Contaminated Product, or the violation involves a Substance of Abuse and the Athlete established entitlement to a reduced period of Ineligibility under Article 10.2.4.1 of the Code.
A hearing panel’s decision no t to lift a mandatory Provisional Suspension on account of the Athlete’s assertion regarding a Contaminated Product shall not be appealable.
7.6.5 The optional Provisional Suspension may also be lifted if the Athlete or other Person demonstrates to the ITA or CAS Anti -Doping Division that (a) the alleged a nti-doping rule violation has no reasonable prospect of being upheld, or (b) it is likely that he or she bears No Fault or Negligence for the alleged a nti-doping rule violation.
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 27 / 49 7.6.6 If a Provisional Suspension is imposed based on an A Sample Adverse Analytical Finding and subsequent analysis of the B Sample does not confirm the A Sample analysis, then the P rovisional Suspension shall automatically be lifted on account of a violation of Article 2.1 of these Rules .
In circumstances where the Athlete (or the Athlete's team) has been removed from an Event based on a violation of Article 2.1 of these Rules and the subsequent B Sample analysis does not confirm the A Sample finding, then if it is still possible for the Athlete or team to be reinserted without otherwise affecting the Event , the Athlete or team may continue to take part in the Event .
In addition, the Athlete or team may thereafter take part in other Competitions and Events at the Olympic Games Paris 2024.
7.7 Voluntary acceptance of Provisional Suspension 7.7.1 Athletes on their own initiative may voluntarily accept a Provisional Suspension if done so prior to the later of: (i) the expiration of 10 days from the report of B Sample (or waiver of the B Sample ) or 10 days from the notice of any other anti -doping rule violation, or (ii) the date on which the Athlete first competes after such report or notice.
Other Persons on their own initiative may voluntarily accept a Provisional Suspension if done so within 10 days from the notice of the anti -doping rule violation.
7.7.2 Upon such voluntary acceptance, the Provisional Suspension shall have the full effect and be treated in the same manner as if the Provisional Suspension had been imposed under Article 7.6.1 or 7.6.2; provided, however, at any time after voluntarily accepting a Provisional Suspension , the Athlete or other Person may withdraw such acceptance, in which event the Athlete or other Person shall not receive any credit for time previously served during the Provisional Suspension .
7.8 Resolution upon Waiver of Hearing or other Circumstances 7.8.1 An Athlete or other Person against whom an anti -doping rule violation is asserted may expressly waive a hearing and accept the C onsequences that have been offered by the ITA under these Rules .
7.8.2 Alternatively, if the Athlete or other Person against whom an anti -doping rule violation is asserted fails to dispute that assertion within the deadline specified in the notice sent by the ITA, then such Athlete or other Person shall be deemed to have admitted the violation, to have waived a hearing, and to have accepted the proposed Consequences .
7.8.3 In cases where Article 7.
8.1 or Article 7.
8.2 applies, the ITA shall issue a reasoned decision confirming the commission of the anti -doping rule violation and imposing the relevant Consequences .
The ITA shall send copies of that decision to Anti -Doping Organisations with a right to appeal under Article 12.2.2, and that decision shall be promptly reported by the ITA into ADAMS and Publicly Disclose d in accordance with Article 13.3.2.
7.9 Results Management Decisions Results Management decisions or adjudications will address and determine without limitation (i) whether an anti-doping rule violation was committed or a Provisional Suspension should be imposed or maintained , the factual basis for such determination, and the specific articles of these Rules violated, and (ii) all Consequences flowing from the anti-doping rule IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 28 / 49 violation(s), including applicable Disqualifications and other Consequences under Articles 9 , 10.1, 10.2 and 11 of these Rules , any forfeiture of medals , diplomas, points and prizes , and any recovery of costs (if applicable ).
In accordance with Article 7.1.2 of these Rules and Article 7.5 of the Code , the completion of the Results Management of the case in terms of sanctions beyond the Olympic Games Paris 2 024 itself shall be referred to the applicable International Federation.
7.10 Notice of Results Management Decisions Athlete s, other Person s, Signatories and WADA shall be notified of Results Management decisions as provided in Article 13.2 of these Rules and the International Standard for Results Management .
7.11 Reporting information related to Results Management into ADAMS The following information related to Results Management shall be reported into ADAMS : (a) notifications of anti-doping rule violations and related decisions for Adverse Analytical Findings ; (b) notifications and related decisions for other anti -doping rule violations that are not Adverse Analytical Findings ; and (c) any decision imposing or lifting a Provisional Suspension .
7.12 Retirement from Sport If an Athlete or other Person retires while the ITA is conducting the Results Management process, the IOC retains authority to complete its Results Management process.
If an Athlete or other Person retires before any Results Management process has begun, the Anti-Doping Organi sation which would have had Results Management authority over the Athlete or other Person at the time the Athlete or other Person committed an anti-doping rule violation, has authority to conduct the Results Management .
ARTICLE 8 – RESULTS MANAGEMENT : HEARING PROCESS 8.1 CAS Anti- Doping Division 8.1.1 Where the ITA decides to assert an anti -doping rule violation and where Article 7.8 of these Rules does not apply , the ITA shall promptly file an application with the CAS Anti -Doping Division, acting as first- instance authority to conduct proceedings and to issue decisions, as per the CAS Anti-Doping Division Arbitration Rules .
The application shall be filed in the name of the IOC by the ITA acting on the IOC’s behalf.
A copy of such application (which shall be deemed as the notice of charge as defined in the International Standard for Results Management) will be provided to the Athlete , the Athlete ’s NOC, the Athlete ’s International Federation, the relevant National Anti -Doping Organisation of the Athlete ; the IOC and WADA .
8.1.2 The composition of the hearing panel and procedures applicable to the CAS Anti-Doping Division shall be as per the CAS Anti -Doping Division Arbitration Rules .
IOC Anti-Doping Rules applicable to the Games of the XXXIII Olympiad Paris 2024 29 / 49 8.2 Hearings and procedures of the CAS Anti- Doping Division 8.2.1 In all procedures relating to any alleged anti -doping rule violation pursuant to these Rules, the right of any Person to be heard pursuant to paragraph 3 to the Bye -law to Rule 59 of the Olympic Charter will be exercised solely before the CAS Anti -Doping Division or the ITA (in the context of Article 7.8 of these Rules , exclusively) .
Pursuant to Rule 59.2.4 of the Olympic Charter, the IOC Executive Board delegates to the CAS Anti -Doping Division all powers which are necessary for it to take the measures and sanctions envisaged by these Rules including, in particular, Articles 9, 10.1, 10.2 and 11.
The same applies to the ITA in the context of Article 7.8 of these Rules .
Hearings may proceed following the assertion of one or more of the anti -doping rule violations set out in Article 2.1 through Article 2.
11 of these Rules .
8.2.2 The CAS Anti -Doping Division shall issue a timely reasoned decision.
The CAS Anti -Doping Division shall promptly notify such decision to the Athlete or other Person concerned, the IOC, the ITA, the Athlete ’s or other Person ’s NOC, the International Federation concerned, the National Anti -Doping Organisation of the Athlete ’s or other Person ’s country of residence or countries where the Person is a national or license holder, a representative of the Independent Observer Program me (during the Period of the Olympic Games Paris 2024 ) and WADA of such decision .
8.2.3 The decision of the CAS Anti -Doping Division shall also be reported by the ITA into ADAMS and Publicly Disclosed as provided in Article 13.3 and may be appealed as provided in Article 12.
Article 13.3.6 shall be applied in cases involving a Minor, a Protected Person or a Recreational Athlete .
8.3 Single Hearing Before CAS In accordance with the Arbitration Rules of the CAS Anti -Doping Division, anti-doping rule violations asserted against an Athlete or other Person may, with the consent of the Athlete or other Person , the ITA and WADA , be heard by the CAS Anti-Doping Division acting as a sole instance subject to the conditions set forth in the Arbitration Rules of the CAS Anti -Doping Division.
Such decision shall not be construed as an admission of the anti -doping rule violation, a waiver to a hearing and to the right to a wri tten defence, and/or an acceptance of the Consequences applicable under these Rules , as referred to in Article 7.
8 above.